GRFS
Grifols, S.A.
NASDAQ · Healthcare · Drug Manufacturers - General · ES
$7.80
−1.02%Margins
Gross margin
37.2%
EBITDA margin
23.5%
EBIT margin
16.7%
Net margin
6.1%
FCF margin
9.7%
8.2%
Return on equity
2.3%
Return on assets
8.8%
Return on invested capital
0.37x
Asset turnover
$1.3B
Cash from operations
$0.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026